MYRIEL PHARMACEUTICALS, LLC – Trademark Portfolio

Entity Type: 16

MYRIEL PHARMACEUTICALS, LLC holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. Currently, 1 trademark is registered. Notable registered marks include INTRAROSA. The owner is based in Bridgewater, NJ.

200 Crossing Boulevard

Bridgewater, NJ 08807

12 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EVRA
EVRA
Abandoned 2024
ANSAID
ANSAID
Abandoned 2023
MELLARIL
MELLARIL
Abandoned 2022
AMCILL
AMCILL
Abandoned 2022
ACEON
ACEON
Abandoned 2022
DALMANE
DALMANE
Abandoned 2022
HYZYD
HYZYD
Abandoned 2022
ORAP
ORAP
Abandoned 2022
INTRAROSA
INTRAROSA
Registered 2015

Trademark Classifications

MYRIEL PHARMACEUTICALS, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (12 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does MYRIEL PHARMACEUTICALS, LLC have?

MYRIEL PHARMACEUTICALS, LLC has 12 U.S. trademarks filed with the USPTO. Of these, 1 registered, 11 abandoned.

What trademark classes does MYRIEL PHARMACEUTICALS, LLC file in?

MYRIEL PHARMACEUTICALS, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are MYRIEL PHARMACEUTICALS, LLC's most well-known trademarks?

MYRIEL PHARMACEUTICALS, LLC's registered trademark portfolio includes well-known marks such as INTRAROSA. These are among 1 currently registered trademark in the portfolio.

What is MYRIEL PHARMACEUTICALS, LLC's trademark registration success rate?

MYRIEL PHARMACEUTICALS, LLC has a 8% trademark registration rate, with 1 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.